Organogenesis Holdings Inc.
ORGO
$2.48
$0.104.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -53.16M | 43.70M | 21.57M | -9.39M | -18.84M |
| Total Depreciation and Amortization | 9.88M | 4.86M | 4.87M | 4.58M | 4.29M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.13M | 34.52M | 6.52M | 10.06M | 15.34M |
| Change in Net Operating Assets | 70.53M | -43.67M | -29.88M | -38.12M | -20.71M |
| Cash from Operations | 21.13M | 39.42M | 3.08M | -32.87M | -19.94M |
| Capital Expenditure | -3.15M | -4.65M | -2.24M | -3.64M | -3.63M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.15M | -4.65M | -2.24M | -3.64M | -3.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.84M | -302.00K | -296.00K | -288.00K | -285.00K |
| Issuance of Common Stock | -- | 2.00K | 130.00K | 0.00 | 25.00K |
| Repurchase of Common Stock | -3.05M | -87.00K | -2.00K | 0.00 | -1.80M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.32M | -4.42M | -10.04M | -- | -- |
| Cash from Financing | -20.21M | -4.81M | -10.21M | -288.00K | -2.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.23M | 29.96M | -9.36M | -36.80M | -25.62M |